跳至主要内容
临床试验/JPRN-UMIN000028295
JPRN-UMIN000028295已完成未知

Single-Site,Single Blind, Placebo-Controlled Study of Gluten Digesting Enzymes as Modulators of Gluten Intolerance Symptoms. - Single-Site, Single Blind, Placebo-Controlled Study of Gluten Digesting Enzymes as Modulators of Gluten Intolerance Symptoms.

Amano Enzyme Inc.0 个研究点目标入组 40 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Subjects with a diagnosis of celiac disease proven by a biopsy 2.Subjects with uncontrolled chronic health conditions such as Type I and Type II diabetes, cardiovascular disease, etc. 3. Women who are pregnant, intending to become pregnant during the study period or currently lactating. 4. Subjects with certain combinations of serum antibodies indicating the possibility of celiac disease (strongly positive for both anti-transglutaminase and anti-gliadin antibodies; see Appendix 4).

研究者

相似试验